Correlation Between Eupraxia Pharmaceuticals and Medexus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Medexus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Medexus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Medexus Pharmaceuticals, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Medexus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Medexus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Medexus Pharmaceuticals.
Diversification Opportunities for Eupraxia Pharmaceuticals and Medexus Pharmaceuticals
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eupraxia and Medexus is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Medexus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medexus Pharmaceuticals and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Medexus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medexus Pharmaceuticals has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Medexus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Medexus Pharmaceuticals
Assuming the 90 days trading horizon Eupraxia Pharmaceuticals is expected to generate 0.93 times more return on investment than Medexus Pharmaceuticals. However, Eupraxia Pharmaceuticals is 1.08 times less risky than Medexus Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Medexus Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 534.00 in Eupraxia Pharmaceuticals on April 25, 2025 and sell it today you would earn a total of 167.00 from holding Eupraxia Pharmaceuticals or generate 31.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Medexus Pharmaceuticals
Performance |
Timeline |
Eupraxia Pharmaceuticals |
Medexus Pharmaceuticals |
Eupraxia Pharmaceuticals and Medexus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eupraxia Pharmaceuticals and Medexus Pharmaceuticals
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Medexus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Medexus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medexus Pharmaceuticals will offset losses from the drop in Medexus Pharmaceuticals' long position.Eupraxia Pharmaceuticals vs. Primaris Retail RE | Eupraxia Pharmaceuticals vs. Kua Investments | Eupraxia Pharmaceuticals vs. CNJ Capital Investments | Eupraxia Pharmaceuticals vs. Vizsla Silver Corp |
Medexus Pharmaceuticals vs. Cipher Pharmaceuticals | Medexus Pharmaceuticals vs. Eupraxia Pharmaceuticals | Medexus Pharmaceuticals vs. Knight Therapeutics | Medexus Pharmaceuticals vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |